Despite strong cash flow and organic growth in most of its key brands, high leverage and mixed valuation ratios lead to a ...
GSK has announced a new collaboration with local university and medical researchers, while Editas Medicine has a deal to ...
The allergy treatment market is set to experience robust growth, with an estimated valuation of US$ 20.20 billion in 2022 and ...
The global cryoglobulinemia treatment market is poised for significant growth, with an expected market value of US$ 496 ...
Hosted on MSN10h
GSK’s Arexvy Vaccine Shows Promise for Broader UseGlaxoSmithKline (GB:GSK) has released an update. GSK has announced promising new data for its RSV vaccine, Arexvy, which ...
Today, Cerebras Systems, the pioneer in high performance AI compute, smashed its previous industry record for inference, ...
In a letter, advocates call for officials to hold long-term care facilities and nursing homes accountable for providing ...
The global ulcerated necrobiosis lipoidica management market is poised for significant growth, with an anticipated valuation ...
Dr. Ernest Mario, a leader in the pharmaceutical industry, passed away at his son’s home in Durham, NC, on October 20, 2024, ...
Report Ocean has published a new report on the Singapore Nutritional Supplements Market, delivering an extensive analysis of key factors such as market restraints, drivers, and opportunities. The ...
After making a splash in the U.K. earlier this year, GSK is laying out plans for its biggest U.S. manufacturing investment ...
On Thursday, GSK plc (NYSE:GSK) revealed new preliminary data for Arexvy (Respiratory Syncytial Virus Vaccine, Adjuvanted) in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback